Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| SBBU/IREC-25-32] | Other Identifier | [ShaheedBenazirBhuttoUSheringalDU] |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Khyber Medical University Peshawar | OTHER |
Not provided
Not provided
Not provided
Not provided
This study is a Phase I randomized clinical trial aiming to investigate the short-term effects of three commonly prescribed statins i.e (Atorvastatin, Rosuvastatin, and Simvastatin) at different dose levels i.e lo,median and high doses on cardiovascular parameters i.e Blood pressure and ECG morphology in healthy volunteers. The study will assess changes in blood pressure and ECG morphology following two days of statin administration under controlled conditions.
The goal of this study is to evaluate the effects of these three statins on the cardiovascular parameters in a dose-dependent manner. In this Phase 1 clinical trial we will enroll healthy volunteers who will be randomized to receive one of three statins at low, moderate, or high doses for two days. .
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Rosuvastatin (5mg, 20mg, 40mg) | Experimental | The assigned participants will be given Rosuvastatin 5mg, 20mg, 40mg OD for two days |
|
| Atorvastatin (10mg,20mg, 40mg) | Experimental | The assigned participants will be given Atorvastatin 10mg,20mg, 40mg OD for two days |
|
| Simvastatin (10mg, 20mg, 40mg) | Experimental | The assigned participants will be given Simvastatin 10mg, 20mg, 40mg OD for two days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rosuvastatin (5mg, 20mg, 40mg) | Drug | The Rosuvastatin (5mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood Pressure Measurements | Blood Pressure of the subjects will be determined by sphygmomanometer | before dosing and 2 days after dosing achieving peak plasma concentrations respectively] |
| Measure | Description | Time Frame |
|---|---|---|
| Electrocardiograms (ECGs) Measurements | ECGs of the subjects will be determined by 12 Leads ECG Machine.QT interval and QRS complex in milliseconds will be analyzed to determine the effects of these statins on ECG morphology | before dosing and 2 days after dosing achieving peak plasma concentrations respectively] |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dr Abid Ullah, Ph.D | Contact | 09448850 | 527 | abid@sbbu.edu.pk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shaheed Benazir Bhutto University Sheringal Dir Upper | Dīr | Khyber Pakhtunkhwa | Pakistan |
The study results will be shared in well reputable Journals without the participant identifiers
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000068718 | Rosuvastatin Calcium |
| D000069059 | Atorvastatin |
| D019821 | Simvastatin |
| ID | Term |
|---|---|
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D005464 | Fluorobenzenes |
Not provided
Not provided
The selected statins i.e Simvastatin (5mg, 20mg, 40mg), atorvastatin (10mg,20mg, 40mg) and simvastatin(10mg, 20mg, 40mg) will be given orally to the participants of different assigned randomized participants groups in once daily dosing for two days to assess the effect on blood pressure and ECG.
Not provided
Not provided
The PI will give the assigned medication to each participant according to randomization and allocation. All the personnel involved in the study will be kept blind.
| Atorvastatin (10mg, 20mg, 40mg) | Drug | The Atorvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
|
| Simvastatin (10mg, 20mg, 40m | Drug | The Simvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days |
|
| D006845 |
| Hydrocarbons, Fluorinated |
| D006846 | Hydrocarbons, Halogenated |
| D006838 | Hydrocarbons |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D011743 | Pyrimidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D011758 | Pyrroles |
| D001393 | Azoles |
| D006538 | Heptanoic Acids |
| D005227 | Fatty Acids |
| D008055 | Lipids |
| D008148 | Lovastatin |
| D009281 | Naphthalenes |
| D011084 | Polycyclic Aromatic Hydrocarbons |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D011083 | Polycyclic Compounds |